Silver, Richard T.
Hasselbalch, Hans Carl https://orcid.org/0000-0003-3936-8032
Article History
Received: 21 September 2025
Revised: 10 January 2026
Accepted: 30 January 2026
First Online: 8 April 2026
Competing interests
: RTS is Chair of the Data Safety Monitoring Board, SURPASS Study, PharmaEssentia, Inc. HCH has received research grants from Novartis and Pharmand Gmbh; advisory board AOP Orphan, Pharmand Gmbh, Incyte; personal fees from AOP Orphan and PharmaEssentia.